TMDX TransMedics Group, Inc.

Develops a proprietary system for preserving human organs for transplant

$44.24  +2.01 (4.75%)
As of 10/04/2022 13:13:11 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  05/02/2019
Outstanding shares:  28,093,949
Average volume:  439,603
Market cap:   $1,172,641,431
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BK6TM04
Valuation   (See tab for details)
PE ratio:   -25.32
PB ratio:   19.72
PS ratio:   30.00
Return on equity:   -78.22%
Net income %:   -119.88%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy